News Focus
News Focus
Replies to #88667 on Biotech Values
icon url

genisi

01/08/10 11:40 AM

#88670 RE: DewDiligence #88667

I think that many docs are waiting for outcomes data of Tekturna and its class.
icon url

poorgradstudent

01/08/10 12:44 PM

#88676 RE: DewDiligence #88667

>For people who don’t benefit from the ACE/ARB classes and are looking to combat hypertension only, I would think Tekturna might be a better option<

Same pathway... ;-)